Related Experiment Video

Updated: Jun 28, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Haploidentical SCT in children: an update and future perspectives

P Lang1, R Handgretinger

  • 1Department of Haematology/Oncology, Children's University Hospital, University of Tuebingen, Tuebingen, Germany. prlang@med.uni-tuebingen.de

Bone Marrow Transplantation
|November 26, 2008
PubMed

Insights

Haploidentical stem cell transplants offer a donor for most patients, with T and B cell depletion showing promise in reducing GVHD and improving engraftment, especially for pediatric cancers.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Haploidentical stem cell transplantation (HSCT) is a vital treatment, expanding donor availability for patients with malignant diseases.
  • Graft manipulation techniques are crucial for optimizing HSCT outcomes.

Purpose of the Study:

  • To review current outcomes and novel strategies in haploidentical HSCT, with a focus on pediatric malignant diseases.
  • To evaluate the efficacy of different graft manipulation methods and supportive care strategies.

Main Methods:

  • Review of current literature on haploidentical HSCT, focusing on graft manipulation techniques like CD34(+) selection and T/B cell depletion.
  • Analysis of outcomes including graft-versus-host disease (GVHD), engraftment, survival, and treatment-related mortality (TRM).

Main Results:

  • T and B cell depletion effectively reduces GVHD and achieves high primary engraftment (83-100%) with sufficient stem cell doses.
  • Disease-free survival at 3 years for acute lymphoblastic leukemia (ALL) in remission ranges from 22-48%.
  • Reduced-intensity conditioning and proactive viral management improved TRM, primarily due to viral infections.

Conclusions:

  • T and B cell depletion is a promising strategy for haploidentical HSCT, improving engraftment and reducing GVHD.
  • Optimized conditioning regimens and vigilant infection control are key to reducing TRM.
  • Further research is needed to improve outcomes for patients with active disease at transplantation, exploring novel cell therapies and treatments.

More Related Videos

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review05:06

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review

Published on: March 27, 2026

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...